抗着丝点抗体水平与同种型与系统性硬化症发展
基线IgG和IgM ACA水平在明确SSc中更高,且极早期SSc患者基线IgG ACA水平较高与5年内进展为明确SSc相关。
要点
- 基线IgG ACA水平较高与极早期SSc进展为明确SSc相关。
- 明确SSc患者的IgG和IgM ACA水平高于极早期SSc患者。
- ACA同种型水平可能作为极早期SSc进展风险的生物标志物。
核心结论
- ACA同种型水平可能有助于识别有进展为明确SSc风险的极早期SSc患者。
主要发现
- 明确SSc患者IgG ACA水平较高(OR 2.5,95%CI 1.8-3.7),IgM ACA水平亦较高(OR 1.8,95%CI 1.3-2.3)。
- 115例有随访的极早期SSc患者中,48例(42%)在5年内进展为明确SSc。
- 进展为明确SSc与基线IgG ACA水平较高相关(OR 4.3,95%CI 1.7-10.7)。
关键数值与推荐
- 极早期SSc定义为IgG ACA阳性且伴有雷诺现象和/或肿胀手指和/或甲襞毛细血管镜异常,但不满足ACR/EULAR 2013分类标准。
临床怎么用
- 对极早期SSc患者可检测ACA同种型水平,辅助评估进展为明确SSc的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Little is known on the disease course of very early systemic sclerosis (SSc). Among the information yet to be elucidated is whether anticentromere antibody (ACA) isotype levels can serve as biomarkers for future SSc development and for organ involvement. This study was undertaken to evaluate whether IgG, IgM, and IgA ACA levels in IgG ACA-positive patients are associated with disease severity and/or progression from very early SSc to definite SSc. METHODS: IgG ACA-positive patients from 5 different cohorts who had very early SSc or SSc fulfilling the American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) 2013 criteria were included. A diagnosis of very early SSc was based on the presence of IgG ACAs and Raynaud's phenomenon, and/or puffy fingers and/or abnormal nailfold capillaroscopy, but not fulfilling the ACR/EULAR 2013 criteria for SSc. Multivariable regression analyses were performed to determine the association between baseline ACA isotype levels and progression to definite SSc with organ involvement. RESULTS: Six hundred twenty-five IgG ACA-positive patients were included, of whom 138 (22%) fulfilled the criteria for very early SSc and 487 (78%) had definite SSc. Levels of IgG ACAs (odds ratio 2.5 [95% confidence interval 1.8-3.7]) and IgM ACAs (odds ratio 1.8 [95% confidence interval 1.3-2.3]) were significantly higher in patients with definite SSc. Of 115 patients with very early SSc with follow-up, progression to definite SSc occurred within 5 years in 48 (42%). Progression to definite SSc was associated with higher IgG ACA levels at baseline (odds ratio 4.3 [95% confidence interval 1.7-10.7]). CONCLUSION: ACA isotype levels may serve as biomarkers to identify patients with very early SSc who are at risk for disease progression to definite SSc.
引用
- van Leeuwen NM, Boonstra M, Bakker JA, et al. Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis. Arthritis Rheumatol. 2021. PMID: 34042326. doi:10.1002/art.41814
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。